EUVIMEDEUVIMED entdecken
VergleichsstudieLeitlinieOpen Access · CC BY-NC 4.0

Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years

Danish Abdul Aziz iD, Muhammad Aqib Sajjad iD, Ameema Asad

Monaldi Archives for Chest Disease · 2023

DOI: 10.4081/monaldi.2023.2701 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Monaldi Archives for Chest Disease, 2023. Verfasst von Danish Abdul Aziz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi. Hauptthemen laut MEDLINE: Asthma, Adrenal Cortex Hormones, Practice Guidelines as Topic, Anti-Asthmatic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Global Initiative for Asthma (GINA) 2021 guidelines for asthma have been set forth with some alterations in Step 3, for children from 6-11-year-old age group. The low dose LABA-ICS, very low dose formoterol-ICS, medium dose ICS and ICS-LTRA combination were recommended in the guideline. We organized this study to draw an effective comparison between these three combinations of controller therapies in pediatric population. A retrospective study was conducted at the Aga Khan University Hospital, Karachi, Pakistan which enrolled 114 children aged 6-11 years old, from July 2021 to December 2022. These children were admitted with asthma exacerbations and were discharged on controller medications as per GINA guidelines on step 3 for control of asthma for 3 months. They were then followed for re-admission within 30 days of discharge, number of ER visits with asthma exacerbations for 1 year, number of admissions with asthma including HDU and PICU admissions, length of stay per admission for all admissions in subsequent one year. The pulmonary function test was done at 1 week follow-up in clinic after discharge and at 3 months visit post discharge. A total of 114 pediatric patients from age 6-11-year-old, were enrolled in the study period out of which 36 (31.57%), 33(28.9%) and 34 (29.82%) patients were categorized into ICS-LABA, ICS and ICS-LTRA groups respectively. ER visits were significantly low in ICS-LABA group followed by ICS-LRTA group and then ICS group (1.75±0.96 vs 2.93±1.412 vs 3.11±1.21, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaAdrenal Cortex HormonesPractice Guidelines as TopicAnti-Asthmatic AgentsHumansChildRetrospective StudiesFemaleMaleAdministration, InhalationDrug Therapy, CombinationLeukotriene AntagonistsPakistanFormoterol FumarateAdrenergic beta-2 Receptor Agonists

Substanzen

Adrenal Cortex HormonesAnti-Asthmatic AgentsLeukotriene AntagonistsFormoterol FumarateAdrenergic beta-2 Receptor Agonists

Autor:innen und Institutionen

  • Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi.

ORCID-Profile: Danish Abdul Aziz, Muhammad Aqib Sajjad

Zitieren

APA

Aziz, D. A., Sajjad, M. A., & Asad, A. (2023). Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2023.2701

Vancouver

Aziz DA, Sajjad MA, Asad A. Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years. Monaldi Archives for Chest Disease. 2023. doi:10.4081/monaldi.2023.2701

BibTeX
@article{Aziz2023,
  author = {Aziz, Danish Abdul and Sajjad, Muhammad Aqib and Asad, Ameema},
  title = {Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years},
  journal = {Monaldi Archives for Chest Disease},
  year = {2023},
  doi = {10.4081/monaldi.2023.2701}
}
Kostenlos starten →